These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 15957009)

  • 1. The selective 5-HT6 receptor antagonist Ro4368554 restores memory performance in cholinergic and serotonergic models of memory deficiency in the rat.
    Lieben CK; Blokland A; Sik A; Sung E; van Nieuwenhuizen P; Schreiber R
    Neuropsychopharmacology; 2005 Dec; 30(12):2169-79. PubMed ID: 15957009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the novel 5-HT(6) receptor antagonist RO4368554 in rat models for cognition and sensorimotor gating.
    Schreiber R; Vivian J; Hedley L; Szczepanski K; Secchi RL; Zuzow M; van Laarhoven S; Moreau JL; Martin JR; Sik A; Blokland A
    Eur Neuropsychopharmacol; 2007 Mar; 17(4):277-88. PubMed ID: 16989988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two novel 5-HT6 receptor antagonists ameliorate scopolamine-induced memory deficits in the object recognition and object location tasks in Wistar rats.
    de Bruin NM; Prickaerts J; van Loevezijn A; Venhorst J; de Groote L; Houba P; Reneerkens O; Akkerman S; Kruse CG
    Neurobiol Learn Mem; 2011 Sep; 96(2):392-402. PubMed ID: 21757018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models.
    Hirst WD; Stean TO; Rogers DC; Sunter D; Pugh P; Moss SF; Bromidge SM; Riley G; Smith DR; Bartlett S; Heidbreder CA; Atkins AR; Lacroix LP; Dawson LA; Foley AG; Regan CM; Upton N
    Eur J Pharmacol; 2006 Dec; 553(1-3):109-19. PubMed ID: 17069795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procognitive profiling of a serotonin 5-HT
    Gyertyán I; Kassai F; Kozma K; Kitka T; Ernyey AJ
    Brain Res Bull; 2020 Dec; 165():238-245. PubMed ID: 33086133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of scopolamine-induced and age-associated memory impairments by the sigma and 5-hydroxytryptamine(1A) receptor agonist OPC-14523 (1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2[1H]-quinolinone monomethanesulfonate).
    Tottori K; Nakai M; Uwahodo Y; Miwa T; Yamada S; Oshiro Y; Kikuchi T; Altar CA
    J Pharmacol Exp Ther; 2002 Apr; 301(1):249-57. PubMed ID: 11907181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NK3 receptor agonist senktide ameliorates scopolamine-induced deficits in memory for object, place and temporal order.
    Schäble S; Huston JP; Barros M; Tomaz C; de Souza Silva MA
    Neurobiol Learn Mem; 2012 Feb; 97(2):235-40. PubMed ID: 22209911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: a potential role for 5-HT1A receptor agonism and 5-HT3 receptor antagonism.
    du Jardin KG; Jensen JB; Sanchez C; Pehrson AL
    Eur Neuropsychopharmacol; 2014 Jan; 24(1):160-71. PubMed ID: 23916504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 5-HT6 antagonists, Ro-4368554 and SB-258585, in tests used for the detection of cognitive enhancement and antipsychotic-like activity.
    Gravius A; Laszy J; Pietraszek M; Sághy K; Nagel J; Chambon C; Wegener N; Valastro B; Danysz W; Gyertyán I
    Behav Pharmacol; 2011 Apr; 22(2):122-35. PubMed ID: 21301322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptations in 5-HT receptor expression and function: implications for treatment of cognitive impairment in aging.
    Mitchell ES; McDevitt RA; Neumaier JF
    J Neurosci Res; 2009 Sep; 87(12):2803-11. PubMed ID: 19396878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral administration of the 5-HT6 receptor antagonists SB-357134 and SB-399885 improves memory formation in an autoshaping learning task.
    Perez-García G; Meneses A
    Pharmacol Biochem Behav; 2005 Jul; 81(3):673-82. PubMed ID: 15964617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective 5-HT1A antagonists WAY 100635 and NAD-299 attenuate the impairment of passive avoidance caused by scopolamine in the rat.
    Misane I; Ogren SO
    Neuropsychopharmacology; 2003 Feb; 28(2):253-64. PubMed ID: 12589378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No effect of acute tryptophan depletion on phosphodiesterase inhibition--related improvements of short-term object memory in male Wistar rats.
    van Donkelaar EL; Prickaerts J; Akkerman S; Rutten K; Steinbusch HW; Blokland A
    Acta Psychiatr Scand; 2013 Aug; 128(2):107-13. PubMed ID: 23772681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUVN-502, a novel, potent, pure, and orally active 5-HT6 receptor antagonist: pharmacological, behavioral, and neurochemical characterization.
    Nirogi R; Abraham R; Benade V; Medapati RB; Jayarajan P; Bhyrapuneni G; Muddana N; Mekala VR; Subramanian R; Shinde A; Kambhampati R; Jasti V
    Behav Pharmacol; 2019 Feb; 30(1):16-35. PubMed ID: 29847336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin-dependent maintenance of spatial performance and electroencephalography activation after cholinergic blockade: effects of serotonergic receptor antagonists.
    Dringenberg HC; Zalan RM
    Brain Res; 1999 Aug; 837(1-2):242-53. PubMed ID: 10434009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PDE4 inhibitor rolipram reverses object memory impairment induced by acute tryptophan depletion in the rat.
    Rutten K; Lieben C; Smits L; Blokland A
    Psychopharmacology (Berl); 2007 Jun; 192(2):275-82. PubMed ID: 17265077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase 2 and 5 inhibition attenuates the object memory deficit induced by acute tryptophan depletion.
    van Donkelaar EL; Rutten K; Blokland A; Akkerman S; Steinbusch HW; Prickaerts J
    Eur J Pharmacol; 2008 Dec; 600(1-3):98-104. PubMed ID: 18957291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive function in rodents: a combined neurochemical and behavioral analysis.
    Millan MJ; Gobert A; Roux S; Porsolt R; Meneses A; Carli M; Di Cara B; Jaffard R; Rivet JM; Lestage P; Mocaer E; Peglion JL; Dekeyne A
    J Pharmacol Exp Ther; 2004 Oct; 311(1):190-203. PubMed ID: 15146031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of a cholinergic-induced deficit in a rodent model of recognition memory by the selective 5-HT6 receptor antagonist, Ro 04-6790.
    Woolley ML; Marsden CA; Sleight AJ; Fone KC
    Psychopharmacology (Berl); 2003 Dec; 170(4):358-67. PubMed ID: 13680084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of regional 5-HT depletion on the cognitive enhancing effects of a typical 5-ht(6) receptor antagonist, Ro 04-6790, in the Novel Object Discrimination task.
    King MV; Spicer CH; Sleight AJ; Marsden CA; Fone KC
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):111-23. PubMed ID: 18839151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.